fda indications for tirzepatide These highlights do not include all the information needed to use ZEPBOUND safely and effectively. See full prescribing information ZEPBOUND. ZEPBOUND® (tirzepatide) Injection, for subcutaneous useInitial U.S. Approval: 2022 FDA approves new weight-loss drug
Pay in 4 interest-free payments of $5.03 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9



























